DSA联合CT引导下经皮肾穿刺造口术在恶性肿瘤所致肾盂积水中的临床应用  

Clinical application of DSA combined with CT-guided percutaneous nephrostomy in treating hydronephrosis caused by malignant tumors

作　　者：黄斌[1] 熊正平[1] 李国文[1] 黄满平[1] 古善智[1] 周石[1] 贵 

机构地区：[1]长沙中南大学湘雅医学院附属肿瘤医院介入科,410013 [2]阳医学院附属医院介入科,410013

出　　处：《介入放射学杂志》2013年第6期478-481,共4页Journal of Interventional Radiology

摘　　要：目的探讨DSA联合CT引导下经皮穿刺肾造口(PCN)在恶性肿瘤所致肾盂积水中的临床价值。方法 2005年8月—2011年11月在DSA联合CT引导下对67例肾盂积水患者行PCN治疗,其中34例患者行双侧PCN,分析治疗效果及并发症。结果 67例患者共93次置管,均一次性成功,成功率100%。所有患者肾功能1周内得到改善并恢复,有效率100%。无一例患者出现严重出血、感染及脏器损伤和因治疗所致相关并发症而导致的死亡。结论 DSA联合CT引导下PCN术安全、高效、并发症少,对改善恶性肿瘤所导致的输尿管梗阻引起的肾功能损害具有重要的临床意义。Objective To assess the clinical value of DSA combined with CT-guided percutaneous nephrostomy in treating hydronephrosis caused by malignant tumors. Methods During the period from August 2005 to December 2011 at authors＇ hospital, DSA combined with CT- guided percutaneous nephrostomy was performed in 67 patients with hydronephrosis caused by malignant tumors. Of the 67 patients, bilateral percutaneous nephrostomy was carried out in 34. The therapeutic results and the complications were analyzed. Results A total of 93 procedures of percutaneous nephrostomy were accomplished in 67 patients with a technical success rate of 100%. The renal function was obviously improved and significantly recovered in all patients within one week after the procedure with an effective rate of 100%. No massive bleeding, infection, visceral damage or death due to procedure-related complications occurred. Conclusion For the treatment of renal function impairment due to ureteral obstructive hydronephrosis that is caused by malignant tumors, DSA combined with CT-guided percutaneous nephrostomy is safe and highly effective with fewer complications. （J Intervent Radiol, 2013, 22：478-481 ）

关 键 词：肾盂积水 恶性肿瘤 经皮肾造瘘术 DSA联合CT引导 

分 类 号：R730.6[医药卫生—肿瘤]